Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome–like skeletal defects induced by Pdk1 or Cbp mutations in mice

Jae‐Hyuck Shim(UMass Memorial Health Care), Laurie H. Glimcher(Harvard University Press)
Journal of Clinical Investigation
December 2, 2011
Cited by 23


Related Papers